Natural Killer Cell Presence in Antibody-Mediated RejectionMatthias Diebold, Georg A. Böhmig, Nicolas Kozakowski et al.|Transplant International|2024Cited by 19
225.3: Randomized phase 2 trial of felzartamab in humoral transplant rejection.Katharina A. Mayer, Georg A. Böhmig, Eva Schrezenmeier et al.|Transplantation|2024Cited by 0